NCT06314243View on ClinicalTrials.gov

The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

July 10, 2025

Conditions
Hemodialysis Patients
Interventions
DIETARY_SUPPLEMENT

"Pumpkin Seed Oil Ronkin®, KMT PHARMA, Egypt. "

Ronkin soft gelatin capsules, each containing 1010 mg of pumpkin seed oil (Latin name: Curcurbita pepo), standardized to contain palmitic acid (8-15%), stearic acid (3-8%), oleic acid (15-35%), linoleic acid (40-65%), and other fatty acids (≤ 2.4%)

Trial Locations (1)

11766

Adult Nephrology and Dialysis Unit, Ain Shams University Hospital, Cairo, Egypt., Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06314243 - The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients | Biotech Hunter | Biotech Hunter